Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo
Preskorn, S.H.; Alderman, J.; Greenblatt, D.J.; Horst, W.D.
Psychopharmacology Bulletin 33(4): 659-665
1997
ISSN/ISBN: 0048-5764 PMID: 9493476 Document Number: 482975
The in vivo effect of sertraline on oxidative drug metabolism mediated by cytochrome P450 (CYP) 3A was assessed by coadministration with alprazolam, carbamazepine, and terfenadine in three separate studies. Sertraline at doses of 50 to 200 mg/day for 10 to 20 days did not after the pharmacokinetics of these CYP3A substrates/drugs.
Document emailed within 1 workday
Related Documents
Reidy, G.F.; Mehta, I.; Murray, M. 1989: Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics Molecular Pharmacology 35(5): 736-743Mattammal, M.B.; Zenser, T.V.; Palmier, M.O.; Davis, B.B. 1985: Renal reduced nicotinamide adenine dinucleotide phosphate:cytochrome c reductase-mediated metabolism of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide Cancer Research 45(1): 149-156
Rapeport, W.G.; Williams, S.A.; Muirhead, D.C.; Dewland, P.M.; Tanner, T.; Wesnes, K. 1996: Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine Journal of Clinical Psychiatry 57(Suppl): 20-23
Svensson, C.K.; Knowlton, P.W. 1987: Effect of encainide on in vivo drug metabolism in the rat Research Communications in Chemical Pathology and Pharmacology 56(2): 285-288
Chen, L-Ming.; Liang, Y-Ju.; Zhang, X.; Su, X-Dong.; Dai, C-Ling.; Wang, F-Peng.; Yan, Y-Yan.; Tao, L-Yang.; Fu, L-Wu. 2009: Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue Anticancer Research 29(11): 4597-4604
Abernathy, C.O.; Zimmerman, H.J.; Utili, R. 1980: Effects of endotoxin-tolerance on in vivo drug metabolism in mice Research Communications in Chemical Pathology and Pharmacology 29(1): 193-196
Park, S.S.; Fujino, T.; West, D.; Guengerich, F.P.; Gelboin, H.V. 1982: Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450 Cancer Research 42(5): 1798-1808
Remmer, H. 1976: Drug metabolism in the human liver measured with in vitro and in vivo methods Arzneimittel-Forschung 26(6): 1262-1263
Gallenkamp, H.; Sundermann, D.; Brachtel, D.; Grün, M.; Rasenack, U.; Rietbrock, I.; Liehr, H.; Richter, E. 1974: Effect of a choline-deficient diet on drug metabolism in the rat in vivo and in vitro Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1558-1561
Zhang, X.-s.; Wang, Y.-x.; Huang, X.-y.; Leng, J.; Li, Z.; Han, Y.-f. 2005: Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation Zhonghua Nan Ke Xue 11(7): 520
Raynaud, F.I.; Boxall, F.E.; Goddard, P.; Barnard, C.F.; Murrer, B.A.; Kelland, L.R. 1996: Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products Anticancer Research 16(4a): 1857-1862
Thomas, P.E.; Lu, A.Y.; West, S.B.; Ryan, D.; Miwa, G.T.; Levin, W. 1977: Accessibility of cytochrome P450 in microsomal membranes: inhibition of metabolism by antibodies to cytochrome P450 Molecular Pharmacology 13(5): 819-831
Wallen, N.; Kita, H.; Weiler, D.; Gleich, G.J. 1991: Glucocorticoids inhibit cytokine-mediated eosinophil survival Journal of Immunology 147(10): 3490-3495
Koudriakova, T.; Iatsimirskaia, E.; Utkin, I.; Gangl, E.; Vouros, P.; Storozhuk, E.; Orza, D.; Marinina, J.; Gerber, N. 1998: Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(6): 552-561
Leng, P.; Brown, D.R.; Shivakumar, C.V.; Deb, S.; Deb, S.P. 1995: N-terminal 130 amino acids of MDM2 are sufficient to inhibit p53-mediated transcriptional activation Oncogene 10(7): 1275-1282
Kadokami, T.; Shimokawa, H.; Fukumoto, Y.; Ito, A.; Takayanagi, T.; Egashira, K.; Takeshita, A. 1996: Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1 beta in vivo Circulation 94(2): 190-196
Farrell, G.C.; Cooksley, W.G.; Hart, P.; Powell, L.W. 1978: Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism Gastroenterology 75(4): 580-588
Gutman, M.; Szold, A.; Ravid, A.; Lazauskas, T.; Merimsky, O.; Klausner, J.M. 1996: Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo Anticancer Research 16(6b): 3673-3677
Ruzicka, J.A.; Ruenitz, P.C. 1992: Cytochrome P-450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(5): 770-772
Richieri, G.V.; Kleinfeld, A.M. 1990: Free fatty acids inhibit cytotoxic T lymphocyte-mediated lysis of allogeneic target cells Journal of Immunology 145(4): 1074-1077